Analysts Set agilon health, inc. (NYSE:AGL) Price Target at $3.95

Shares of agilon health, inc. (NYSE:AGL) have been given an average rating of “Hold” by the seventeen ratings firms that are currently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a sell recommendation, thirteen have assigned a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $3.95.

A number of brokerages have weighed in on AGL. Needham & Company LLC reaffirmed a “hold” rating on shares of agilon health in a research note on Friday, March 21st. Citigroup upgraded agilon health from a “sell” rating to a “neutral” rating and boosted their price target for the company from $1.75 to $2.25 in a research note on Friday, January 10th. Sanford C. Bernstein increased their target price on shares of agilon health from $2.50 to $3.15 and gave the stock a “market perform” rating in a report on Wednesday, January 15th. Macquarie started coverage on agilon health in a research note on Monday, December 16th. They issued a “neutral” rating and a $3.00 price objective for the company. Finally, Stifel Nicolaus raised their target price on shares of agilon health from $2.00 to $3.00 and gave the company a “hold” rating in a research note on Wednesday, February 26th.

Hedge Funds Weigh In On agilon health

Several institutional investors have recently modified their holdings of the company. Wealth Enhancement Advisory Services LLC acquired a new position in shares of agilon health in the 4th quarter worth $155,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of agilon health by 24.6% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 797,658 shares of the company’s stock worth $1,516,000 after purchasing an additional 157,610 shares during the last quarter. Two Sigma Advisers LP raised its holdings in agilon health by 4,393.5% during the fourth quarter. Two Sigma Advisers LP now owns 480,800 shares of the company’s stock valued at $914,000 after buying an additional 470,100 shares in the last quarter. Two Sigma Investments LP raised its stake in shares of agilon health by 73.7% in the 4th quarter. Two Sigma Investments LP now owns 857,867 shares of the company’s stock valued at $1,630,000 after acquiring an additional 363,855 shares in the last quarter. Finally, State of Wyoming lifted its stake in shares of agilon health by 89.3% in the fourth quarter. State of Wyoming now owns 122,504 shares of the company’s stock worth $233,000 after buying an additional 57,802 shares during the last quarter.

agilon health Stock Performance

NYSE AGL opened at $4.14 on Friday. The company has a 50-day simple moving average of $3.74 and a two-hundred day simple moving average of $2.99. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health has a 12-month low of $1.50 and a 12-month high of $7.73. The firm has a market cap of $1.70 billion, a price-to-earnings ratio of -4.40 and a beta of 0.38.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.